🔴 Cue Biopharma is trading 7.2% down — reason remains unclear

Cue Biopharma is trading 7.2% lower at $19.36 on November 4, 2026, with no clear reason identified.

• No company-specific announcement or other clear catalyst was identified in available reports.
• Major U.S. indexes and the biotech sector were higher; available evidence does not support attributing the decline to broad-market or sector weakness.
• The prior session’s biotech rally does not explain the decline.